Gilead Sciences Rebounds from Market Slump Amid Strong Catalyst Performance

Pharmaceutical giant Gilead Sciences is experiencing a significant financial recovery after overcoming a prolonged period of declining performance. Analysts attribute the turnaround primarily to a key product or strategic initiative that is driving substantial revenue growth.